Close Menu

Crohn's disease

A Washington University-led team detected differences in gut virus diversity in those with inflammatory bowel disease.

Enterome Bioscience is collaborating with AbbVie to create molecular diagnostic tools to monitor the gut microbiome in patients with Crohn's disease and other microbiome-related diseases.

NEW YORK (GenomeWeb News) – The nonprofit Crohn's and Colitis Canada has awarded nearly C$800,000 (US$740,000) to fund three omics research projects that will investigate genes involved in inflammatory bowel diseases (IBD) and a possible method for treating such diseases.

NEW YORK (GenomeWeb News) – A new study is spelling out some of the distinct gut microbiome features found in individuals diagnosed with Crohn's disease who have not yet received treatment for the condition.

NEW YORK (GenomeWeb News) – The Ontario Genomics Institute said today that it has provided funding to Tissue Regeneration Therapeutics (TRT), a company developing umbilical stem cell-based treatments for a range of diseases, that will support 'omics-based research projects.

This article was originally posted Aug. 23.

NEW YORK (GenomeWeb News) –Genisphere and the Lankenau Institute for Medical Research today said that they have expanded their research collaboration aimed at identifying microRNA biomarkers to include Crohn's Disease and other inflammatory bowel disorders.

BRB, which is also developing similar tests for other cancers and autoimmune diseases, has partnered with lab testing services firm Clinical Reference Laboratory for clinical validation of its tests.

The test is made up of six serologic markers and three genetic mutation markers.

Pages

The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.

The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.

News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.

In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.